High-Density Lipoprotein: A Novel Target for Antirestenosis Therapy

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Restenosis is an integral pathological process central to the recurrent vessel narrowing after interventional procedures. Although the mechanisms for restenosis are diverse in different pathological conditions, endothelial dysfunction, inflammation, vascular smooth muscle cell (SMC) proliferation, and myofibroblasts transition have been thought to play crucial role in the development of restenosis. Indeed, there is an inverse relationship between high-density lipoprotein (HDL) levels and risk for coronary heart disease (CHD). However, relatively studies on the direct assessment of HDL effect on restenosis are limited. In addition to involvement in the cholesterol reverse transport, many vascular protective effects of HDL, including protection of endothelium, antiinflammation, antithrombus actions, inhibition of SMC proliferation, and regulation by adventitial effects may contribute to the inhibition of restenosis, though the exact relationships between HDL and restenosis remain to be elucidated. This review summarizes the vascular protective effects of HDL, emphasizing the potential role of HDL in intimal hyperplasia and vascular remodeling, which may provide novel prophylactic and therapeutic strategies for antirestenosis.

Original languageEnglish
Pages (from-to)500-511
Number of pages12
JournalClinical and Translational Science
Volume7
Issue number6
DOIs
StatePublished - Dec 1 2014

Fingerprint

HDL Lipoproteins
Cell proliferation
Smooth Muscle Myocytes
Blood Vessels
Muscle
Therapeutics
Cell Proliferation
Tunica Intima
Adventitia
Myofibroblasts
Pathologic Processes
Vascular Smooth Muscle
Endothelium
Hyperplasia
Coronary Disease
Cholesterol
Inflammation

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

High-Density Lipoprotein : A Novel Target for Antirestenosis Therapy. / Yin, Kai; Agrawal, Devendra K.

In: Clinical and Translational Science, Vol. 7, No. 6, 01.12.2014, p. 500-511.

Research output: Contribution to journalReview article

@article{ab270292e9f843229f0b93f383a843c6,
title = "High-Density Lipoprotein: A Novel Target for Antirestenosis Therapy",
abstract = "Restenosis is an integral pathological process central to the recurrent vessel narrowing after interventional procedures. Although the mechanisms for restenosis are diverse in different pathological conditions, endothelial dysfunction, inflammation, vascular smooth muscle cell (SMC) proliferation, and myofibroblasts transition have been thought to play crucial role in the development of restenosis. Indeed, there is an inverse relationship between high-density lipoprotein (HDL) levels and risk for coronary heart disease (CHD). However, relatively studies on the direct assessment of HDL effect on restenosis are limited. In addition to involvement in the cholesterol reverse transport, many vascular protective effects of HDL, including protection of endothelium, antiinflammation, antithrombus actions, inhibition of SMC proliferation, and regulation by adventitial effects may contribute to the inhibition of restenosis, though the exact relationships between HDL and restenosis remain to be elucidated. This review summarizes the vascular protective effects of HDL, emphasizing the potential role of HDL in intimal hyperplasia and vascular remodeling, which may provide novel prophylactic and therapeutic strategies for antirestenosis.",
author = "Kai Yin and Agrawal, {Devendra K.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1111/cts.12186",
language = "English",
volume = "7",
pages = "500--511",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - High-Density Lipoprotein

T2 - A Novel Target for Antirestenosis Therapy

AU - Yin, Kai

AU - Agrawal, Devendra K.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Restenosis is an integral pathological process central to the recurrent vessel narrowing after interventional procedures. Although the mechanisms for restenosis are diverse in different pathological conditions, endothelial dysfunction, inflammation, vascular smooth muscle cell (SMC) proliferation, and myofibroblasts transition have been thought to play crucial role in the development of restenosis. Indeed, there is an inverse relationship between high-density lipoprotein (HDL) levels and risk for coronary heart disease (CHD). However, relatively studies on the direct assessment of HDL effect on restenosis are limited. In addition to involvement in the cholesterol reverse transport, many vascular protective effects of HDL, including protection of endothelium, antiinflammation, antithrombus actions, inhibition of SMC proliferation, and regulation by adventitial effects may contribute to the inhibition of restenosis, though the exact relationships between HDL and restenosis remain to be elucidated. This review summarizes the vascular protective effects of HDL, emphasizing the potential role of HDL in intimal hyperplasia and vascular remodeling, which may provide novel prophylactic and therapeutic strategies for antirestenosis.

AB - Restenosis is an integral pathological process central to the recurrent vessel narrowing after interventional procedures. Although the mechanisms for restenosis are diverse in different pathological conditions, endothelial dysfunction, inflammation, vascular smooth muscle cell (SMC) proliferation, and myofibroblasts transition have been thought to play crucial role in the development of restenosis. Indeed, there is an inverse relationship between high-density lipoprotein (HDL) levels and risk for coronary heart disease (CHD). However, relatively studies on the direct assessment of HDL effect on restenosis are limited. In addition to involvement in the cholesterol reverse transport, many vascular protective effects of HDL, including protection of endothelium, antiinflammation, antithrombus actions, inhibition of SMC proliferation, and regulation by adventitial effects may contribute to the inhibition of restenosis, though the exact relationships between HDL and restenosis remain to be elucidated. This review summarizes the vascular protective effects of HDL, emphasizing the potential role of HDL in intimal hyperplasia and vascular remodeling, which may provide novel prophylactic and therapeutic strategies for antirestenosis.

UR - http://www.scopus.com/inward/record.url?scp=84916597174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916597174&partnerID=8YFLogxK

U2 - 10.1111/cts.12186

DO - 10.1111/cts.12186

M3 - Review article

C2 - 25043950

AN - SCOPUS:84916597174

VL - 7

SP - 500

EP - 511

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 6

ER -